Stephen K. Brannan Karuna Therapeutics, Inc. (KRTX) insider trading activity

KRTX Quotes by TradingView

Stephen K. Brannan is Chief Medical Officer of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 09, 2023, when has been sold 5,000 shares (Common Stock) at a price of $197.52 per share, resulting in proceeds of $987,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Stephen K. Brannan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2023
SELL
Open market or private sale
$987,600 $197.52 p/Share
5,000 Reduced 25.0%
15,000 Common Stock
Jan 09 2023
BUY
Exercise of conversion of derivative security
$31,800 $6.36 p/Share
5,000 Added 21.3%
18,473 Common Stock
Dec 09 2022
SELL
Open market or private sale
$1,003,800 $200.76 p/Share
5,000 Reduced 25.0%
15,000 Common Stock
Dec 09 2022
BUY
Exercise of conversion of derivative security
$41,200 $8.24 p/Share
5,000 Added 23.4%
16,363 Common Stock
Nov 09 2022
SELL
Open market or private sale
$1,080,000 $216.0 p/Share
5,000 Reduced 25.0%
15,000 Common Stock
Nov 09 2022
BUY
Exercise of conversion of derivative security
$46,000 $9.2 p/Share
5,000 Added 20.0%
20,000 Common Stock
Oct 10 2022
SELL
Open market or private sale
$1,037,550 $207.51 p/Share
5,000 Reduced 25.0%
15,000 Common Stock
Oct 10 2022
BUY
Exercise of conversion of derivative security
$46,000 $9.2 p/Share
5,000 Added 20.0%
20,000 Common Stock
Sep 09 2022
SELL
Open market or private sale
$1,217,300 $243.46 p/Share
5,000 Reduced 25.0%
15,000 Common Stock
Sep 09 2022
BUY
Exercise of conversion of derivative security
$36,350 $7.27 p/Share
5,000 Added 20.0%
20,000 Common Stock
Aug 09 2022
SELL
Open market or private sale
$5,702,250 $228.09 p/Share
25,000 Reduced 62.5%
15,000 Common Stock
Aug 09 2022
BUY
Exercise of conversion of derivative security
$197,750 $7.91 p/Share
25,000 Added 47.83%
27,264 Common Stock
Jul 11 2022
SELL
Open market or private sale
$1,999,350 $133.29 p/Share
15,000 Reduced 50.0%
15,000 Common Stock
Jul 11 2022
BUY
Exercise of conversion of derivative security
$138,000 $9.2 p/Share
15,000 Added 33.33%
30,000 Common Stock
Jun 09 2022
SELL
Open market or private sale
$554,500 $110.9 p/Share
5,000 Reduced 25.0%
15,000 Common Stock
Jun 09 2022
BUY
Exercise of conversion of derivative security
$46,000 $9.2 p/Share
5,000 Added 20.0%
20,000 Common Stock
May 09 2022
SELL
Open market or private sale
$520,500 $104.1 p/Share
5,000 Reduced 25.0%
15,000 Common Stock
May 09 2022
BUY
Exercise of conversion of derivative security
$46,000 $9.2 p/Share
5,000 Added 20.0%
20,000 Common Stock
Apr 01 2022
SELL
Open market or private sale
$992,662 $128.45 p/Share
7,728 Reduced 34.0%
15,000 Common Stock
Apr 01 2022
BUY
Exercise of conversion of derivative security
$65,050 $6.36 p/Share
10,228 Added 31.04%
22,728 Common Stock
Mar 01 2022
SELL
Open market or private sale
$829,833 $107.38 p/Share
7,728 Reduced 38.2%
12,500 Common Stock
Mar 01 2022
BUY
Exercise of conversion of derivative security
$74,971 $7.33 p/Share
10,228 Added 33.58%
20,228 Common Stock
Feb 01 2022
SELL
Open market or private sale
$850,466 $110.05 p/Share
7,728 Reduced 43.59%
10,000 Common Stock
Feb 01 2022
BUY
Exercise of conversion of derivative security
$65,050 $6.36 p/Share
10,228 Added 36.59%
17,728 Common Stock
Jan 03 2022
SELL
Open market or private sale
$1,010,745 $130.79 p/Share
7,728 Reduced 25.57%
22,500 Common Stock
SKB

Stephen K. Brannan

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRTX